Half-Life Cancer Research Results
Half-Life, Half-Life: Click to Expand ⟱
| Source: |
| Type: |
For many drugs, the half-life is the time it takes for half of the drug’s active substance to be eliminated from the bloodstream.
In medicine, knowing a drug’s half-life helps in designing treatment regimens that reduce adverse effects.
|
Nor, Normal Healthy: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
*Half-Life↝, BioAv↝, *Half-Life↓, BioAv↑, *Dose↝,
*BioAv↓, *Half-Life↓, *toxicity↓, *ROS↑, GSH↓, selectivity↑,
Risk↓, *Inflam↓, *COX1↓, *AntiAg↑, *Half-Life↓, *BioAv↑,
*BioAv↝, *other↝, *Half-Life↓,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
*BBB↓, *GutMicro↑, Obesity↓, *Inflam↓, *AntiCan↑, *TRPV1↑, *Ca+2↑, *antiOx↑, *cardioP↑, *BioAv↓, *Half-Life↓, *BioAv↝, *BioAv↑, *neuroP↑, Apoptosis↑, p38↑, ROS↑, MMP↓, MPT↑, Cyt‑c↑, Casp↑, TRIB3↑, NADH↓, SIRT1↓, TumCG↓, TumCMig↓, TOP1↓, TOP2↓, β-catenin/ZEB1↓, *ROS↓, *Aβ↓,
*BioAv↝, *BioAv↓, *ROS⇅, *NRF2↑, *BioAv↑, *Half-Life↓, *BioAv↑, *BioAv↑, BioAv↑,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
NA, |
AD, |
NA |
|
|
|
*antiOx↑, *ROS↓, *cognitive↑, *neuroP↑, *SIRT1↑, *AMPK↑, *GPx↑, *HO-1↑, *GSK‐3β↑, *COX2↓, *PGE2↓, *NF-kB↓, *NO↓, *Casp3↓, *MMP3↓, *MMP9↓, *MMP↑, *GSH↑, *other↑, *BioAv↑, *memory↑, *GlutMet↑, *BioAv↓, *Half-Life↓, *toxicity∅,
Showing Research Papers: 1 to 7 of 7
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 7
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
GSH↓, 1, NADH↓, 1, ROS↑, 1,
Mitochondria & Bioenergetics ⓘ
MMP↓, 1, MPT↑, 1,
Core Metabolism/Glycolysis ⓘ
SIRT1↓, 1,
Cell Death ⓘ
Apoptosis↑, 1, Casp↑, 1, Cyt‑c↑, 1, p38↑, 1,
Proliferation, Differentiation & Cell State ⓘ
TOP1↓, 1, TOP2↓, 1, TumCG↓, 1,
Migration ⓘ
TRIB3↑, 1, TumCMig↓, 1, β-catenin/ZEB1↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↑, 2, BioAv↝, 1, selectivity↑, 1,
Clinical Biomarkers ⓘ
TRIB3↑, 1,
Functional Outcomes ⓘ
Obesity↓, 1, Risk↓, 1,
Total Targets: 22
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 2, GPx↑, 1, GSH↑, 1, HO-1↑, 1, NRF2↑, 1, ROS↓, 2, ROS↑, 1, ROS⇅, 1,
Mitochondria & Bioenergetics ⓘ
MMP↑, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 1, GlutMet↑, 1, SIRT1↑, 1,
Cell Death ⓘ
Casp3↓, 1, TRPV1↑, 1,
Transcription & Epigenetics ⓘ
other↑, 1, other↝, 1,
Proliferation, Differentiation & Cell State ⓘ
GSK‐3β↑, 1,
Migration ⓘ
AntiAg↑, 1, Ca+2↑, 1, MMP3↓, 1, MMP9↓, 1,
Angiogenesis & Vasculature ⓘ
NO↓, 1,
Barriers & Transport ⓘ
BBB↓, 1,
Immune & Inflammatory Signaling ⓘ
COX1↓, 1, COX2↓, 1, Inflam↓, 2, NF-kB↓, 1, PGE2↓, 1,
Protein Aggregation ⓘ
Aβ↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 4, BioAv↑, 6, BioAv↝, 3, Dose↝, 1, Half-Life↓, 7, Half-Life↝, 1,
Clinical Biomarkers ⓘ
GutMicro↑, 1,
Functional Outcomes ⓘ
AntiCan↑, 1, cardioP↑, 1, cognitive↑, 1, memory↑, 1, neuroP↑, 2, toxicity↓, 1, toxicity∅, 1,
Total Targets: 43
Scientific Paper Hit Count for: Half-Life, Half-Life
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:1109 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page